A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

Conditions: Depressive Disorder, Treatment-Resistant

Interventions: Drug: Esketamine 56 mg; Drug: Esketamine 84 mg; Drug: Placebo

Sponsors: Janssen Research & Development, LLC

Not yet recruiting